![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/00 | |
A61K 45/06 | |||
A61K 31/155 | |||
C07D 223/16 | |||
A23P 20/12 | |||
A61K 31/55 | |||
A61K 9/20 | |||
A61K 9/28 | |||
A61K 31/135 |
(11) | Number of the document | 2611427 |
(13) | Kind of document | T |
(96) | European patent application number | 11755504.5 |
Date of filing the European patent application | 2011-08-31 | |
(97) | Date of publication of the European application | 2013-07-10 |
(45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/049914 |
Date | 2011-08-31 |
(87) | Number | WO 2012/030927 |
Date | 2012-03-08 |
(30) | Number | Date | Country code |
403143 P | 2010-09-10 | US | |
402578 P | 2010-09-01 | US |
(72) |
SHAO, Zezhi Jesse, US
BLACKBURN, Anthony C., US
GROTTICK, Andrew J., US
MORGAN, Michael, US
RUETER, Jaimie Karyn, US
SHIFRINA, Anna, US
STIRN, Scott, US
YANG, Libo, US
YOON, Woo Hyun, US
|
(73) |
Arena Pharmaceuticals, Inc.,
6154 Nancy Ridge Drive, San Diego, CA 92121,
US
|
(54) | MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT |
MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT |